Home NDC 62032-907-07 Obagi Skintrinsiq Antioxidant Protocol
Product NDC 62032-907
Requested package NDC 62032-907-07
11-digit product format 620320907
Labeler code 62032
Product ID 62032-907_8299732b-f96d-45fe-ae06-058f296cad1e
Type HUMAN OTC DRUG
Nonproprietary name AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, and OXYBENZONE
Dosage form KIT
Labeler Obagi Cosmeceuticals LLC
Application M020
Marketing category OTC MONOGRAPH DRUG
Marketing start 2021-08-01
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 7 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-04-01 02:39 UTC · source 2025-03-31 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 U Excluded because listing certification expired 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 U Excluded because listing certification expired ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 U Excluded because listing certification expired 0efc9e666f02…f202fb6c5f17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Obagi Skintrinsiq Antioxidant Protocol
Listing expiration 2027-12-31 Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 62032-050-54 Obagi Skintrinsiq Antioxidant Protocol 1 in 1 CARTON CREAM 80 mg in 1g 4 62032-050-54 Obagi Skintrinsiq Antioxidant Protocol 48 g in 1 TUBE CREAM 48 g 80 mg in 1g 4 62032-907-07 Obagi Skintrinsiq Antioxidant Protocol 1 in 1 BOX KIT 1 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 62032-907 OBAGI SKINTRINSIQ ANTIOXIDANT PROTOCOL (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE) KIT [OBAGI COSMECEUTICALS LLC] 3 Current NDC, Legacy NDC, 3 package rows 20250406_495bc176-b292-448f-a5a6-00de2e475e54.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 81 of 354 · 7,077 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 62032-907-07 62032090707 1 KIT in 1 BOX (62032-907-07) * 1 BOTTLE, DROPPER in 1 CARTON > 30 mL in 1 BOTTLE, DROPPER * 1 BOTTLE, PUMP in 1 CARTON > 30 mL in 1 BOTTLE, PUMP * 1 BOTTLE, PUMP in 1 CARTON > 48 g in 1 BOTTLE, PUMP * 59 mL in 1 BOTTLE, PLASTIC * 60 mL in 1 BOTTLE, PLASTIC 1 kit 2021-08-01 0000-00-00 No No Current